Correlation Between Dominari Holdings and CytomX Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dominari Holdings and CytomX Therapeutics, you can compare the effects of market volatilities on Dominari Holdings and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and CytomX Therapeutics.

Diversification Opportunities for Dominari Holdings and CytomX Therapeutics

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Dominari and CytomX is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and CytomX Therapeutics go up and down completely randomly.

Pair Corralation between Dominari Holdings and CytomX Therapeutics

Given the investment horizon of 90 days Dominari Holdings is expected to generate 1.43 times less return on investment than CytomX Therapeutics. But when comparing it to its historical volatility, Dominari Holdings is 2.16 times less risky than CytomX Therapeutics. It trades about 0.02 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  247.00  in CytomX Therapeutics on November 2, 2024 and sell it today you would lose (159.00) from holding CytomX Therapeutics or give up 64.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dominari Holdings  vs.  CytomX Therapeutics

 Performance 
       Timeline  
Dominari Holdings 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Dominari Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak primary indicators, Dominari Holdings demonstrated solid returns over the last few months and may actually be approaching a breakup point.
CytomX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CytomX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Dominari Holdings and CytomX Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dominari Holdings and CytomX Therapeutics

The main advantage of trading using opposite Dominari Holdings and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.
The idea behind Dominari Holdings and CytomX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device